Seaside Therapeutics, based in Cambridge, is a pioneering leader in rare disease medicine, exemplified by its commitment to advancing the rare disease community.
Ultragenyx, a subsidiary of Seaside Therapeutics, is at the forefront of driving progress in the field of rare disease treatment, dedicated to propelling the rare disease community forward.
Generated from their website's infomation